Photodegradation of the H<sub>1</sub> Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent Phototoxicity

In this study, important H<sub>1</sub> antihistaminic drugs, i.e., emedastine (EME), epinastine (EPI), and ketotifen (KET), were irradiated with UV/Vis light (300–800 nm) in solutions of different pH values. Next, they were analyzed by new high performance liquid chromatography (HPLC) me...

Full description

Bibliographic Details
Main Authors: Anna Gumieniczek, Anna Berecka-Rycerz, Urszula Hubicka, Paweł Żmudzki, Karolina Lejwoda, Paweł Kozyra
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/12/6/560
_version_ 1797565068594905088
author Anna Gumieniczek
Anna Berecka-Rycerz
Urszula Hubicka
Paweł Żmudzki
Karolina Lejwoda
Paweł Kozyra
author_facet Anna Gumieniczek
Anna Berecka-Rycerz
Urszula Hubicka
Paweł Żmudzki
Karolina Lejwoda
Paweł Kozyra
author_sort Anna Gumieniczek
collection DOAJ
description In this study, important H<sub>1</sub> antihistaminic drugs, i.e., emedastine (EME), epinastine (EPI), and ketotifen (KET), were irradiated with UV/Vis light (300–800 nm) in solutions of different pH values. Next, they were analyzed by new high performance liquid chromatography (HPLC) methods, in order to estimate the percentage of degradation and respective kinetics. Subsequently, ultra-performance liquid chromatography tandem-mass spectrometry (UPLC-MS/MS) was used to identify their photodegradation products and to propose degradation pathways. In addition, the peroxidation of linoleic acid and generation of singlet oxygen (SO) and superoxide anion (SA) were examined, together with the molar extinction coefficient (MEC) evaluation, to estimate their phototoxic risk. The photodegradation of all EME, EPI, and KET followed pseudo first-order kinetics. At pH values of 7.0 and 10.0, EPI was shown to be rather stable. However, its photostability was lower at pH 3.0. EME was shown to be photolabile in the whole range of pH values. In turn, KET was shown to be moderately labile at pH 3.0 and 7.0. However, it degraded completely in the buffer of pH 10.0. As a result, several photodegradation products were separated and identified using the UPLC-MS/MS method. Finally, our ROS assays showed a potent phototoxic risk in the following drug order: EPI < EME < KET. All of these results may be helpful for manufacturing, storing, and applying these substantial drugs, especially in their ocular formulations.
first_indexed 2024-03-10T19:06:46Z
format Article
id doaj.art-1a396a7052dd4e66aab5d78c5b25db20
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T19:06:46Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-1a396a7052dd4e66aab5d78c5b25db202023-11-20T04:05:47ZengMDPI AGPharmaceutics1999-49232020-06-0112656010.3390/pharmaceutics12060560Photodegradation of the H<sub>1</sub> Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent PhototoxicityAnna Gumieniczek0Anna Berecka-Rycerz1Urszula Hubicka2Paweł Żmudzki3Karolina Lejwoda4Paweł Kozyra5Department of Medicinal Chemistry, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, PolandDepartment of Medicinal Chemistry, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, PolandDepartment of Inorganic and Analytical Chemistry, Jagiellonian University, Collegium Medicum, Medyczna 9, 30-688 Cracow, PolandDepartment of Medicinal Chemistry, Jagiellonian University, Collegium Medicum, Medyczna 9, 30-688 Cracow, PolandDepartment of Medicinal Chemistry, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, PolandDepartment of Medicinal Chemistry, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, PolandIn this study, important H<sub>1</sub> antihistaminic drugs, i.e., emedastine (EME), epinastine (EPI), and ketotifen (KET), were irradiated with UV/Vis light (300–800 nm) in solutions of different pH values. Next, they were analyzed by new high performance liquid chromatography (HPLC) methods, in order to estimate the percentage of degradation and respective kinetics. Subsequently, ultra-performance liquid chromatography tandem-mass spectrometry (UPLC-MS/MS) was used to identify their photodegradation products and to propose degradation pathways. In addition, the peroxidation of linoleic acid and generation of singlet oxygen (SO) and superoxide anion (SA) were examined, together with the molar extinction coefficient (MEC) evaluation, to estimate their phototoxic risk. The photodegradation of all EME, EPI, and KET followed pseudo first-order kinetics. At pH values of 7.0 and 10.0, EPI was shown to be rather stable. However, its photostability was lower at pH 3.0. EME was shown to be photolabile in the whole range of pH values. In turn, KET was shown to be moderately labile at pH 3.0 and 7.0. However, it degraded completely in the buffer of pH 10.0. As a result, several photodegradation products were separated and identified using the UPLC-MS/MS method. Finally, our ROS assays showed a potent phototoxic risk in the following drug order: EPI < EME < KET. All of these results may be helpful for manufacturing, storing, and applying these substantial drugs, especially in their ocular formulations.https://www.mdpi.com/1999-4923/12/6/560H<sub>1</sub> antihistaminicstopical formulationsphotodegradation kineticsphotodegradation pathwaysphototoxicityreactive oxygen species
spellingShingle Anna Gumieniczek
Anna Berecka-Rycerz
Urszula Hubicka
Paweł Żmudzki
Karolina Lejwoda
Paweł Kozyra
Photodegradation of the H<sub>1</sub> Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent Phototoxicity
Pharmaceutics
H<sub>1</sub> antihistaminics
topical formulations
photodegradation kinetics
photodegradation pathways
phototoxicity
reactive oxygen species
title Photodegradation of the H<sub>1</sub> Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent Phototoxicity
title_full Photodegradation of the H<sub>1</sub> Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent Phototoxicity
title_fullStr Photodegradation of the H<sub>1</sub> Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent Phototoxicity
title_full_unstemmed Photodegradation of the H<sub>1</sub> Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent Phototoxicity
title_short Photodegradation of the H<sub>1</sub> Antihistaminic Topical Drugs Emedastine, Epinastine, and Ketotifen and ROS Tests for Estimations of Their Potent Phototoxicity
title_sort photodegradation of the h sub 1 sub antihistaminic topical drugs emedastine epinastine and ketotifen and ros tests for estimations of their potent phototoxicity
topic H<sub>1</sub> antihistaminics
topical formulations
photodegradation kinetics
photodegradation pathways
phototoxicity
reactive oxygen species
url https://www.mdpi.com/1999-4923/12/6/560
work_keys_str_mv AT annagumieniczek photodegradationofthehsub1subantihistaminictopicaldrugsemedastineepinastineandketotifenandrostestsforestimationsoftheirpotentphototoxicity
AT annabereckarycerz photodegradationofthehsub1subantihistaminictopicaldrugsemedastineepinastineandketotifenandrostestsforestimationsoftheirpotentphototoxicity
AT urszulahubicka photodegradationofthehsub1subantihistaminictopicaldrugsemedastineepinastineandketotifenandrostestsforestimationsoftheirpotentphototoxicity
AT pawełzmudzki photodegradationofthehsub1subantihistaminictopicaldrugsemedastineepinastineandketotifenandrostestsforestimationsoftheirpotentphototoxicity
AT karolinalejwoda photodegradationofthehsub1subantihistaminictopicaldrugsemedastineepinastineandketotifenandrostestsforestimationsoftheirpotentphototoxicity
AT pawełkozyra photodegradationofthehsub1subantihistaminictopicaldrugsemedastineepinastineandketotifenandrostestsforestimationsoftheirpotentphototoxicity